0001493152-21-022217.txt : 20210908 0001493152-21-022217.hdr.sgml : 20210908 20210908170037 ACCESSION NUMBER: 0001493152-21-022217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210903 FILED AS OF DATE: 20210908 DATE AS OF CHANGE: 20210908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saund Saran CENTRAL INDEX KEY: 0001834417 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 211242765 MAIL ADDRESS: STREET 1: C/O MATEON THERAPEUTICS INC. STREET 2: 29397 AGOURA RD SUTIE 107 CITY: AGOURA HILLS STATE: CA ZIP: 91301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncotelic Therapeutics, Inc. CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 29397 AGOURA RD. STREET 2: #107 CITY: AGUORA HILLS STATE: CA ZIP: 91301 FORMER COMPANY: FORMER CONFORMED NAME: MATEON THERAPEUTICS INC DATE OF NAME CHANGE: 20160613 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 4 1 ownership.xml X0306 4 2021-09-03 0 0000908259 Oncotelic Therapeutics, Inc. OTLC 0001834417 Saund Saran 29397 AGOURA RD SUITE 107 AGOURA HILLS, CA 91301 0 1 0 0 Chief Business Officer Stock Options 0.1393 2021-09-03 4 A 0 675000 0 A 2031-09-03 Common Stock 675000 675000 D Stock Options vest as follows: (i) 50% of the options will vest upon the consummation of a qualifying joint venture agreement, licensing agreement, or acquisition transaction (a "Corporate Transaction"); (ii) The remaining 50% on the one-year anniversary of the consummation of a Corporate Transaction. /s/ Saran Saund 2021-09-08